
Geneseeq Technology Inc.
Toronto, Ontario, Canada na.geneseeq.com From their website, Nov 2026
- CLIA
Work here? Claim this listing
About
Geneseeq Technology Inc. provides clinical genetic testing, NGS-based diagnostics, and translational research services for oncology customers, including biopharma, clinicians, hospitals, and researchers. It operates clinical testing and NGS facilities in Toronto, Mississauga, and Nanjing, with products and services focused on cancer and sample types used in precision medicine.
Geneseeq Technology Inc. is a CRDMO in Toronto, Canada, founded in 2012. It lists 7 services, including Central lab testing, Local testing solutions and IVD kit solutions. It names CLIA on its listing.
Services
Central lab testing
NGS-based genetic tests on multiple sample types to support precision cancer care and treatment decisions.
Local testing solutions
All-inclusive kits, protocols, reagents, and automated bioinformatics software for performing genomic testing in a local laboratory.
IVD kit solutions
In vitro diagnostic NGS kit development and manufacturing for cancer testing and companion diagnostics.
RUO kit solutions
Research-use-only kits for studying cancer-related biomarkers and disease mechanisms in human samples.
Research services
End-to-end NGS research support including project design and management, sequencing, QC/QA, and data analysis.
DNA sequencing
DNA sequencing services including WGS, WES, targeted panel sequencing, DNA methylation sequencing, and customer-made library sequencing.
RNA sequencing
RNA sequencing services including whole transcriptome sequencing, small RNA sequencing, and circular RNA sequencing.
- Turnaround
- Five business days
- 1–2 months
- What to send
- Human samples
- FFPE tumor tissue
- Sample volume varies
How to order from Geneseeq Technology Inc.
What to send, as they list it: Human samples; FFPE tumor tissue; Sample volume varies. Turnaround they state: Five business days; 1–2 months. They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- NGS
- Pan-cancer panels
- Cancer-type specific gene panels
- ctDNA liquid biopsy
- MRD monitoring
- Multi-cancer early detection
10 more
- TMB
- MSI
- HRD
- Gene fusion detection
- Companion diagnostic testing
- WGS
- WES
- Targeted panel sequencing
- DNA methylation sequencing
- Whole transcriptome sequencing
- Scale and capacity
- 1,500,000+ clinical samples sequenced
- 350,000+ samples testing capacity per year
- 400+ genes
- 437-gene panel
- 425-gene panel
- 475-gene panel
- 2365 cancer-related genes
- Therapeutic areas
- Oncology
- Precision cancer care
- Solid tumors
- Hematologic malignancies
- NSCLC
Instruments and platforms
- NGS platforms
- High-throughput NGS platforms
Modalities and species
- Modalities
- Cell therapy
- Species and models
- Human samples
- FFPE tumor tissue
- cfDNA
- ctDNA
- Solid tumors
- Hematologic malignancies
- NSCLC
- Plasma
Industries served
- Biopharma
- Research
- Clinical trials
- Oncology
Company
- Type
- CRDMO
- Founded
- 2012
- Team
- 30+ professionals in Toronto; 1500+ staff in Nanjing
Locations
- Address
- 393 University Avenue Toronto, Ontario, M5G 1E6 Canada © 2026 Geneseeq Technology Inc
- Sites
- Mississauga, Canada
- Nanjing, China
- Serves
- Canada, China, 25 provinces across China, global
Contacts
- Phone
- 1-647-714-5020